Literature DB >> 33993572

Esophageal luminal temperature rise during atrial fibrillation ablation is associated with lower radiofrequency electrode distance and baseline impedance.

Mirmilad Khoshknab1, Ling Kuo1,2,3, Tarek Zghaib1, Jeffrey Arkles1, Pasquale Santangeli1, Francis E Marchlinski1, Yuchi Han1, Benoit Desjardins4, Saman Nazarian1.   

Abstract

INTRODUCTION: Esophageal injury during atrial fibrillation (AF) ablation is a life-threatening complication. We sought to measure the association of esophageal temperature attenuation with radiofrequency (RF) electrode impedance, contact force, and distance from the esophagus.
METHODS: The retrospective study cohort included 35 patients with mean age 64 ± 10 years, of whom 74.3% were male, and 40% had persistent AF. All patients had undergone preprocedural cardiac magnetic resonance (CMR) followed by AF ablation with luminal esophageal temperature monitoring. Lesion locations were co-registered with CMR image segmentations of left atrial and esophageal anatomy. Luminal esophageal temperature, time matched RF lesion data, and ablation distance from the nearest esophageal location were collected as panel data.
RESULTS: Luminal esophageal temperature changes corresponding to 3667 distinct lesions, delivered with mean power 27.9 ± 5.5 W over a mean duration of 22.2 ± 10.5 s were analyzed. In multivariable analyses, clustered per patient, examining posterior wall lesions only, and adjusted for lesion power and duration as set by the operator, lesion distance from the esophagus (-0.003°C/mm, p < .001), and baseline impedance (-0.015°C/Ω, p < .001) were associated with changes in luminal esophageal temperature.
CONCLUSION: Esophageal luminal temperature rises are associated with shorter lesion distance from esophagus and lower baseline impedance during RF lesion delivery. When procedural strategy requires RF delivery near the esophagus, selection of sites with higher baseline impedance may improve safety.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; electrophysiology; impedance

Mesh:

Year:  2021        PMID: 33993572      PMCID: PMC8256679          DOI: 10.1111/jce.15097

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873            Impact factor:   2.942


  35 in total

1.  Circuit Impedance Could Be a Crucial Factor Influencing Radiofrequency Ablation Efficacy and Safety: A Myocardial Phantom Study of the Problem and its Correction.

Authors:  Abhishek Bhaskaran; M A Barry; Jim Pouliopoulos; Chrishan Nalliah; Pierre Qian; William Chik; Sujitha Thavapalachandran; Lloyd Davis; Alistair McEwan; Stuart Thomas; Pramesh Kovoor; Aravinda Thiagalingam
Journal:  J Cardiovasc Electrophysiol       Date:  2016-01-27

2.  Assessment of temperature, proximity, and course of the esophagus during radiofrequency ablation within the left atrium.

Authors:  Jennifer E Cummings; Robert A Schweikert; Walid I Saliba; J David Burkhardt; Johannes Brachmann; Jens Gunther; Volker Schibgilla; Atul Verma; MarkAlain Dery; John L Drago; Fethi Kilicaslan; Andrea Natale
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

3.  Atrial fibrillation ablation with esophageal cooling with a cooled water-irrigated intraesophageal balloon: a pilot study.

Authors:  Takeshi Tsuchiya; Keiichi Ashikaga; Susumu Nakagawa; Kiyoshi Hayashida; Hiroshi Kugimiya
Journal:  J Cardiovasc Electrophysiol       Date:  2006-12-01

Review 4.  Gastrointestinal complications associated with catheter ablation for atrial fibrillation.

Authors:  Lohit Garg; Jalaj Garg; Nancy Gupta; Neeraj Shah; Parasuram Krishnamoorthy; Chandrasekar Palaniswamy; Babak Bozorgnia; Andrea Natale
Journal:  Int J Cardiol       Date:  2016-09-24       Impact factor: 4.164

5.  Real-time monitoring of luminal esophageal temperature during left atrial radiofrequency catheter ablation for atrial fibrillation: observations about esophageal heating during ablation at the pulmonary vein ostia and posterior left atrium.

Authors:  Christian Perzanowski; Liane Teplitsky; Patrick M Hranitzky; Tristram D Bahnson
Journal:  J Cardiovasc Electrophysiol       Date:  2006-02

6.  Global Survey of Esophageal Injury in Atrial Fibrillation Ablation: Characteristics and Outcomes of Esophageal Perforation and Fistula.

Authors:  Chirag R Barbhaiya; Saurabh Kumar; Yu Guo; Judy Zhong; Roy M John; Usha B Tedrow; Bruce A Koplan; Laurence M Epstein; William G Stevenson; Gregory F Michaud
Journal:  JACC Clin Electrophysiol       Date:  2015-12-23

7.  Esophageal perforation during left atrial radiofrequency ablation: Is the risk too high?

Authors:  Nicolas Doll; Michael A Borger; Alexander Fabricius; Susann Stephan; Jan Gummert; Friedrich W Mohr; Johann Hauss; Hans Kottkamp; Gerd Hindricks
Journal:  J Thorac Cardiovasc Surg       Date:  2003-04       Impact factor: 5.209

8.  Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation.

Authors:  Carlo Pappone; Hakan Oral; Vincenzo Santinelli; Gabriele Vicedomini; Christopher C Lang; Francesco Manguso; Lucia Torracca; Stefano Benussi; Ottavio Alfieri; Robert Hong; William Lau; Kirk Hirata; Neil Shikuma; Burr Hall; Fred Morady
Journal:  Circulation       Date:  2004-05-24       Impact factor: 29.690

9.  Intrapericardial balloon placement for prevention of collateral injury during catheter ablation of the left atrium in a porcine model.

Authors:  Shiro Nakahara; Rafael J Ramirez; Eric Buch; Yoav Michowitz; Marmar Vaseghi; Carlos de Diego; Noel G Boyle; Aman Mahajan; Kalyanam Shivkumar
Journal:  Heart Rhythm       Date:  2009-09-17       Impact factor: 6.343

10.  Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values.

Authors:  Moloy Das; Jonathan J Loveday; Gareth J Wynn; Sean Gomes; Yawer Saeed; Laura J Bonnett; Johan E P Waktare; Derick M Todd; Mark C S Hall; Richard L Snowdon; Simon Modi; Dhiraj Gupta
Journal:  Europace       Date:  2017-05-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.